Connect with us

Health

Everything we know about the AstraZeneca COVID-19 vaccine and very rare blood clots – SBS News

Since reports of blood clotting after the AstraZeneca vaccine first emerged, we’ve learned much more about them and are likely to see better outcomes for patients….

Published

on

Article feature image

With COVID-19 community transmission on the rise once again, those aged over 50 are weighing up the benefits of being vaccinated against the virus with the very rare risk of blood clotting induced by the AstraZeneca vaccine.
Since the first reports of blood clotting after the AstraZeneca vaccine emerged in March 2021, our understanding of the clotting disorder, called vaccine-induced thrombotic thrombocytopaenia (VITT) or thrombosis with thrombocytopenia syndrome (TTS), has grown.
We now know how…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending